Evaluation of Mood Disorders Under Biologics in Chronic Inflammatory Rheumatic Disease
Evaluation of Mood Disorders Under Biologics (Anti-TNF Alpha) in Chronic Inflammatory Rheumatic Disease
Centre Hospitalier Universitaire de Besancon
108 participants
May 19, 2021
INTERVENTIONAL
Conditions
Summary
Chronic inflammatory rheumatic diseases (CIRD) affect many organ systems. Painful sensations within the joints spine, hand and foot deformities, low quality of life and psychosocial status in patients with rheumatoid arthritis, spondyloarthritis and psoriatic arthritis can lead to the development of anxiety and depression. Prevalences of anxiety increase in patients suffering of CIRD, compared with healthy individuals. Another connection has been identified by the links between depression and systemic inflammation. It is proven that higher plasma levels of pro-inflammatory cytokines such as tumor necrosis factor alpha (TNFa) affect neurotransmitter metabolism, with influence on patients mood. The purpose of EMOTION study is therefore to analyze thymic variation under TNFa therapy, as treatment of CIRDs.
Eligibility
Inclusion Criteria4
- Adult patients (≥18 ; ≤ 80)
- Patient with rheumatoid arthritis (RA) according to the ACR 2010 criteria, axial or peripheral spondyloarthritis (SpA) according to ASAS criteria, ankylosing spondylitis (AS) according to the New York criteria or psoriatic arthritis (PsA) according to CASPAR criteria
- Signature of informed consent
- Affiliation to a French social security or receiving such a scheme
Exclusion Criteria7
- Patient having previously received anti-TNFα treatment
- Patient with previously diagnosed depressive or psychiatric pathology and / or receiving anti-depressant treatment
- Subjects with limited legal capacity.
- Subjects judged by the investigator to be unlikely to comply with study procedures
- Subjects with no social security coverage.
- Pregnant women.
- Subjects still in the exclusion period of another study, or according to the national registry of clinical trial participants.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Blood sample (20mL) for pro-inflammatory cytokines assay
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04817072